Expression of vasoactive proteins in gastric antral mucosa reflects vascular dysfunction in patients with cirrhosis and portal hypertension
- 10 June 2014
- journal article
- research article
- Published by Wiley in Liver International
- Vol. 35 (4), 1393-1402
- https://doi.org/10.1111/liv.12613
Abstract
Background & Aims Patients with cirrhosis display hypocontractility of splanchnic vessels because of dysregulation of vasoactive proteins, such as decreased effect of RhoA/ROCK and increased activity of β‐Arrestin‐2 and eNOS. However, it is unknown whether the dysregulation of vasoactive proteins is displayed in other vessels. We investigated whether expression of vasoactive proteins can be evaluated in gastric mucosa vessels. Methods Biopsies from the gastric mucosa of 111 patients with cirrhosis were collected at three different centres and from 13 controls. Forty‐nine patients had received TIPS. Portal pressure gradient was measured in 49 patients with TIPS and in 16 patients without TIPS. Biopsies from the antrum were conserved in formaldehyde for immunohistochemistry or shock‐frozen for PCR and Western blot. Results The mucosal transcription of vascular markers (αSMA, CD31) was higher in cirrhotic patients than controls, which was confirmed by immunohistochemistry. On average, relative mucosal levels of RhoA and ROCK were lower, while β‐Arrestin‐2 levels were higher in cirrhotic patients compared to controls. Transcriptional levels of eNOS increased with presence of ascites and grade of oesophageal varices. Patients with TIPS showed less pronounced markers of vascular dysfunction in gastric mucosa. Conclusion This is the first evidence that the expression of vasoactive proteins in mucosa from the gastric antrum of patients with cirrhosis reflects their vascular dysfunction and possibly changes after therapeutic interventions.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (SFB TRR57)
- H. J. & W. Hector Stiftung
- Capital Region of Denmark Foundation of Health Research
- Hvidovre Hospital Foundation for Liver Diseases
This publication has 28 references indexed in Scilit:
- Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signallingLiver International, 2012
- Recent advances in our understanding of hepatorenal syndromeNature Reviews Gastroenterology & Hepatology, 2012
- Pathogenesis of portal hypertensive gastropathy: translating basic research into clinical practiceNature Reviews Gastroenterology & Hepatology, 2009
- Mechanisms of extrahepatic vasodilation in portal hypertensionGut, 2008
- Hemodynamic effects of urotensin II and its specific receptor antagonist palosuran in cirrhotic ratsHepatology, 2007
- Vascular dysfunction in human and rat cirrhosis: Role of receptor-desensitizing and calcium-sensitizing proteinsHepatology, 2007
- Defective RhoA/Rho-Kinase Signaling Contributes to Vascular Hypocontractility and Vasodilation in Cirrhotic RatsGastroenterology, 2006
- The hyperdynamic circulation in cirrhosisPharmacology & Therapeutics, 2001
- The Natural History of Portal Hypertensive Gastropathy: Influence of Variceal EradicationAmerican Journal Of Gastroenterology, 2000
- Natural history of portal hypertensive gastropathy in patients with liver cirrhosisGastroenterology, 2000